Patients with chronic pain and dysphagia (CPD): unmet medical needs and pharmacologic treatment options

References

• Chou R, Fanciullo GJ, Fine PG, et al; American Pain Society–American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113-30
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Helm II S, Fellows B, et al. Opioid epidemic in the United States. Pain Physician 2012;15(3 Suppl):ES9-38
   PubMed Web of Science ®Google Scholar
• Pergolizzi J, Böger RH, Budd K, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 2008;8:287-313
   PubMedGoogle Scholar
• Fox PA, Raina P, Jadad AR. Prevalence and treatment of pain in older adults in nursing homes and other long-term care institutions: a systematic review. Can Med Assoc J 1999;160:329-33
   PubMed Web of Science ®Google Scholar
• Rastogi R, Meek BD. Management of chronic pain in elderly, frail patients: finding a suitable, personalized method of control. Clin Interv Aging 2013;8:37-46
   PubMed Web of Science ®Google Scholar
• Ayres E, Warmington M, Reid MC. Chronic pain perspectives: managing chronic pain in older adults: 6 steps to overcoming medication barriers. J Fam Pract 2012;61(9 Suppl):S16-21
   PubMed Web of Science ®Google Scholar
• Perquin CW, Hazebroek-Kampschreur AA, Hunfeld JA, et al. Chronic pain among children and adolescents: physician consultation and medication use. Clin J Pain 2000;16:229-35
   PubMed Web of Science ®Google Scholar
• Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research, March 2012. Available at: www.iom.edu/relievingpain. Accessed 22 Aug 2014
   Google Scholar
• Sura L, Madhavan A, Carnaby G, Crary MA. Dysphagia in the elderly: management and nutritional considerations. Clin Interv Aging 2012;7:287-98
   PubMed Web of Science ®Google Scholar
• Rofes L, Arreola V, Almirall J, et al. Diagnosis and management of oropharyngeal dysphagia and its nutritional and respiratory complications in the elderly. Gastroenterol Res Pract 2011;2011:818979
   PubMedGoogle Scholar
• Miller AJ. The neurobiology of swallowing and dysphagia. Develop Disab Res Rev 2008;4:77-86
   Google Scholar
• Morris H. Administering drugs to patients with swallowing difficulties. Nurs Times 2005;101:28-30
   PubMedGoogle Scholar
• Zavala SR, Katz PO. Dysphagia and odynophagia. In: Hawkey CJ, Bosch J, Richter JE, et al., eds. Textbook of Clinical Gastroenterology and Hepatology, 2nd Edn. Oxford, UK: Wiley-Blackwell, 2012
   Google Scholar
• Coluzzi PH, Fairbairn BS. The management of pain in terminally ill cancer patients with difficulty swallowing. Amer J Hosp Pallia Med 1999;16:731-7
   PubMedGoogle Scholar
• Pergolizzi JV Jr, Taylor RT Jr, Nalamachu S, et al. Challenges of treating patients with chronic pain with dysphagia (CPD): physician and patient perspectives. Curr Med Res Opin 2014;30:191-202
   Google Scholar
• Chapman CR, Lipschitz DL, Angst MS, et al. Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J Pain 2010;11:807-29
   PubMed Web of Science ®Google Scholar
• Melnikova I. Pain market. Nature Rev Drug Discov 2010;9:589-90
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part I – evidence assessment. Pain Physician 2012;15(3 Suppl):S1-66
   PubMed Web of Science ®Google Scholar
• Rashiq S, Dick BD. Factors associated with chronic noncancer pain in the Canadian population. Pain Res Manag 2009;14:454-60
   PubMed Web of Science ®Google Scholar
• Wright D. Medication administration in nursing homes. Nurs Stand 2002;16:33-8
   PubMedGoogle Scholar
• Mikkelsson M, El-Metwally A, Kautiainen H, et al. Onset, prognosis and risk factors for widespread pain in schoolchildren: a prospective 4-year follow-up study. Pain 2008;138:681-7
   PubMed Web of Science ®Google Scholar
• Huguet A, Miró J. The severity of chronic pediatric pain: an epidemiological study. J Pain 2008;9:226-36
   PubMed Web of Science ®Google Scholar
• Walker LS, Dengler-Crish CM, Rippel S, et al. Functional abdominal pain in childhood and adolescence increases risk for chronic pain in adulthood. Pain 2010;150:568-72
   PubMed Web of Science ®Google Scholar
• King S, Chambers CT, Huguet A, et al. The epidemiology of chronic pain in children and adolescents revisited: a systematic review. Pain 2011;152:2729-38
   PubMed Web of Science ®Google Scholar
• Zernikow B, Wager J, Hechler T, et al. Characteristics of highly impaired children with severe chronic pain: a 5-year retrospective study on 2249 pediatric pain patients. BMC Pediatr 2012;12:54
   PubMed Web of Science ®Google Scholar
• Rhee H, Miles MS, Halpern CT, et al. Prevalence of recurrent physical symptoms in US adolescents. Pediatr Nurs 2005;31:314-50
   PubMedGoogle Scholar
• Forgeron PA, King S, Stinson JN, et al. Social functioning and peer relationships in children and adolescents with chronic pain: a systematic review. Pain Res Manag 2010;15:27-41
   PubMed Web of Science ®Google Scholar
• Swarm R, Abernethy AP, Anghelescu DL, et al; NCCN Adult Cancer Pain. Adult cancer pain. J Natl Compr Canc Netw 2010;8:1046-86
   PubMed Web of Science ®Google Scholar
• Caraceni A, Hanks G, Kaasa S, et al; for the European Palliative Care Research Collaborative (EPCRC); on behalf of the European Association for Palliative Care (EAPC). Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 2012;13:e58-68
   PubMed Web of Science ®Google Scholar
• Ripamonti CI, Bandieri E, Roila F; ESMO Guidelines Working Group. Management of cancer pain: ESMO clinical practice guidelines. Ann Oncol 2011;22(Suppl 6):vi69-77
   PubMedGoogle Scholar
• Van den Beuken-van Everdingen H, de Rijke JM, Kessels AG, et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007;18:1437-49
   PubMed Web of Science ®Google Scholar
• Abernethy AP. Older patients with cancer. A framework for managing pain. Am J Clin Oncol 2007;7:301-6
   Google Scholar
• Bernabei R, Gambassi G, Lapane K, et al. Management of pain in elderly patients with cancer. SAGE Study Group. Systematic assessment of geriatric drug use via epidemiology. JAMA 1998;279:1877-82
   PubMed Web of Science ®Google Scholar
• Howe CL. Cancer pain in the elderly: patient experience and provider treatment. Ariz Geriat Soc 2009;14:29-9
   Google Scholar
• Kaye AD, Baluch A, Scott JT. Pain management in the elderly population. A review. Ochsner J 2010;10:179-87
   PubMedGoogle Scholar
• Miser AW, McCalla J, Dothage JA, et al. Pain as a presenting symptom in children and young adults with newly diagnosed malignancy. Pain 1987;29:85-90
   PubMed Web of Science ®Google Scholar
• Wong IC, Wong LY, Cranswick NE. Minimising medication errors in children. Arch Dis Child 2009;94:161-4
   PubMed Web of Science ®Google Scholar
• Conroy S, Sweis D, Planner C, et al. Interventions to reduce dosing errors in children: a systematic review of the literature. Drug Saf 2007;30:1111-25
   PubMed Web of Science ®Google Scholar
• Barrett JS, Narayan M, Patel D, et al. Prescribing habits and caregiver satisfaction with resources for dosing children: rationale for more informative dosing guidance. BMC Pediatr 2011;2:11-25
   Google Scholar
• Puisieux F, D’Andrea C, Baconnier P, et al; Intergroupe Pneumo Gériatrie SPLF–SFGG placé sous l’égide de la Société de pneumologie de langue française (SPLF) et de la Société française de gériatrie et gerontology (SFGG). Swallowing disorders, pneumonia and respiratory tract infectious disease in the elderly. Rev Mal Respir 2011;28:e76-93
   PubMedGoogle Scholar
• Cichero JA, Altman KW. Definition, prevalence and burden of oropharyngeal dysphagia: a serious problem among older adults worldwide and the impact on prognosis and hospital resources. Nestle Nutr Inst Workshop Ser 2012;72:1-11
   PubMedGoogle Scholar
• Haw C, Stubbs J. Administration of medicines in food and drink: a study of older inpatients with severe mental illness. Int Psychogeriatr 2010;22:409-16
   PubMed Web of Science ®Google Scholar
• Haw C, Stubbs J, Dickens G. An observational study of medication administration errors in old-age psychiatric inpatients. Int J Qual Health Care 2007;19:210-16
   PubMed Web of Science ®Google Scholar
• Stubbs J, Haw C, Dickens G. Dose form modification – a common but potentially hazardous practice. A literature review and study of medication administration to older psychiatric inpatients. Int Psychogeriatr 2008;20:616-27
   PubMed Web of Science ®Google Scholar
• Stegemann S, Gosch M, Breitkreutz J. Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapy. Int J Pharm 2012;430:197-206
   PubMed Web of Science ®Google Scholar
• Carnaby-Mann G, Crary M. Pill swallowing by adults with dysphagia. Arch Otolaryngol Head Neck Surg 2005;131:970-5
   PubMed Web of Science ®Google Scholar
• Jackson LD, Little J, Kung E, et al. Safe medication swallowing in dysphagia: a collaborative improvement project. Healthc Q 2008;11(3 Spec No.):110-16
   PubMedGoogle Scholar
• Spieker MR. Evaluating dysphagia. Amer Fam Phys 2000;61:3639-48
   PubMed Web of Science ®Google Scholar
• Arvedson J, Brodsky L, eds. Pediatric Swallowing and Feeding: Assessment and Management, 2nd Edn. Albany: Singular Publishing Group, Division of Thomson Learning, Inc, 2001:341-88
   Google Scholar
• Chen PH, Golub JS, Hapner ER, Johns MM 3rd. Prevalence of perceived dysphagia and quality-of-life impairment in a geriatric population. Dysphagia 2009;24:1-6
   PubMed Web of Science ®Google Scholar
• Schiele JT, Quinzler R, Klimm HD, et al. Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms. Eur J Clin Pharmacol 2012;69:937-48
   PubMed Web of Science ®Google Scholar
• Wilkins T, Gillies RA, Thomas AM, et al. The prevalence of dysphagia in primary care patients: a HamesNet Research Network study. J Am Board Fam Med 2007;20:144-50
   PubMed Web of Science ®Google Scholar
• Kalf JG, de Swart BJ, Bloem BR, et al. Prevalence of oropharyngeal dysphagia in Parkinson’s disease: a meta-analysis. Parkinsonism Relat Disord 2012;18:311-15
   PubMed Web of Science ®Google Scholar
• Regan J, Sowman R, Walsh I. Prevalence of dysphagia in acute and community mental health settings. Dysphagia 2006;21:95-101
   PubMed Web of Science ®Google Scholar
• Strachan L, Greener M. Medication-related swallowing difficulties may be more common than we realize. Pharm Pract 2005;15:411-14
   Google Scholar
• Kelly J, Wright D, Wood J. Medicine administration errors in patients with dysphagia in secondary care: a multi-centre observational study. J Adv Nurs 2011;67:2615-27
   PubMed Web of Science ®Google Scholar
• Roy N, Stemple J, Merrill RM, Thomas L. Dysphagia in the elderly: preliminary evidence of prevalence, risk factors, and socioemotional effects. Ann Otol Rhinol Laryngol 2007;116:858-65
   PubMed Web of Science ®Google Scholar
• Cabre M, Serra-Prat M, Palomera E, et al. Prevalence and prognostic implications of dysphagia in elderly patients with pneumonia. Age Ageing 2010;39:39-45
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for Industry: Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules (2013). Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM377938.pdf [Last accessed 21 August 2014]
   Google Scholar
• ECRI Health Technology Assessment Group. Diagnosis and Treatment of Swallowing Disorders (Dysphagia) in Acute-Care Stroke Patients Summary. 1999 Mar. In: AHRQ Evidence Report Summaries. Rockville (MD): Agency for Healthcare Research and Quality (US); 1998-2005
   Google Scholar
• Robbins J, Langmore S, Hind JA, et al. Dysphagia research in the 21st century and beyond: proceedings from the Dysphagia Experts Meeting, August 21, 2001. J Rehabil Res Dev 2002;39:543-8
   PubMed Web of Science ®Google Scholar
• Harris Interactive Inc. Pill-Swallowing Problems in America: A National Survey of Adults. New York, NY: Harris Interactive Inc. for Schwarz Pharma, 2003:1-39
   Google Scholar
• Arvedson JC. Assessment of pediatric dysphagia and feeding disorders: clinical and instrumental approaches. Dev Disabil Res Rev 2008;14:118-27
   PubMed Web of Science ®Google Scholar
• Lefton-Greif MA, Arvedson JC. Schoolchildren with dysphagia associated with medically complex conditions. Lang Speech Hear Serv Sch 2008;39:237-48
   PubMed Web of Science ®Google Scholar
• Dosa DM, Dore DD, Mor V, et al. Frequency of long-acting opioid analgesic initiation in opioid-naïve nursing home residents. J Pain Symptom Manage 2009;38:515-21
   PubMed Web of Science ®Google Scholar
• Novy D, Berry MP, Palmer JL, et al. Somatic symptoms in patients with chronic non-cancer-related and cancer-related pain. J Pain Symptom Manage 2005;29:603-12
   PubMed Web of Science ®Google Scholar
• Argoff CE. Pharmacologic management of chronic pain. J Amer Osteopath Assoc 2002;102(9 Suppl 3):S21-7
   PubMedGoogle Scholar
• Katz WA, Barkin RL. Dilemmas in chronic/persistent pain management. Disease-a-Month 2010;56:233-50
   PubMed Web of Science ®Google Scholar
• Turk DC, Wilson HD, Cahana A. Treatment of chronic non-cancer pain. Lancet 2011;377:2226-35
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) Guidelines for Responsible Opioid Prescribing in Chronic Non-Cancer Pain: Part 2 - Guidance. Pain Physician. 2012;15(3 Suppl):S67-S116
   Google Scholar
• Lynch ME, Watson PN. The pharmacotherapy of chronic pain: a review. Pain Res Manag 2006;11:11-38
   PubMedGoogle Scholar
• McMartney C, Sinha A, Katz J. A qualitative systematic review of the role of N-metheyl-D-aspartate receptor antagonists in preventative analgesia. Anesth Analg 2004;98:1385-400
   PubMed Web of Science ®Google Scholar
• Nicholson B. Benefits of extended-release opioid analgesic formulations in the treatment of chronic pain. Pain Pract 2009;9:71-81
   PubMed Web of Science ®Google Scholar
• McCarberg BH, Barkin RL. Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia. Am J Ther 2001;8:181-6
   PubMedGoogle Scholar
• McCarberg BH. The treatment of breakthrough pain. Pain Med 2007;8(S1):S8-13
   PubMedGoogle Scholar
• Radovanovic D, Pjevic M, Malbasa Z, et al. The use of transdermal fentanyl in the treatment of cancer pain. Arch Oncol 2002;10:263-6
   Google Scholar
• Paster RZ. Chronic pain management issues in the primary care setting and the utility of long-acting opioids. Exp Opin Pharmacother 2010;11:1823-33
   PubMed Web of Science ®Google Scholar
• Gudin JA. Assessment of extended-release opioid analgesics for the treatment of chronic pain. J Pain Palliat Pharmacotherap 2013;27:49-61
   PubMedGoogle Scholar
• Trescot AM, Helm S, Hansen H, et al. Opioids in the management of chronic non-cancer pain: An update of American Society of the Interventional Pain Physicians’ (ASIPP) guidelines. Pain Physician 2008;11:S5-62
   PubMed Web of Science ®Google Scholar
• King SJ, Reid C, Forbes K, Hanks G. A systematic review of oxycodone in the management of cancer pain. Palliat Med 2011;25:454-70
   PubMed Web of Science ®Google Scholar
• Caraceni A, Pigni A, Brunelli C. Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project. Palliat Med 2011;25:402-9
   PubMed Web of Science ®Google Scholar
• Reid CM, Martin RM, Sterne JA, et al. Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials. Arch Intern Med 2006;166:837-43
   PubMed Web of Science ®Google Scholar
• McNulty JP. Treatment of chronic pain with methadone or levorphanol. Internat J Pharmaceut Compounds 2006;10:15-16
   Google Scholar
• Fredheim OMS, Moksnes K, Borchgrevink PC, et al. Clinical pharmacology of methadone for pain. Acta Anaesthesiol Scand 2008;52:879-89
   PubMed Web of Science ®Google Scholar
• Bittner BL. Using Opioids in the Management of Chronic Pain Patients: Challenges and Future Options. Leawood, KS: American Academy of Family Physicians, 2010:1-9
   Google Scholar
• Raffa RB, Burmeister JJ, Yuvasheva E, et al. QTc interval prolongation: survey of opioid and nonopioid analgesics. Exp Opin Pharmacother 2012;13:1397-409
   PubMed Web of Science ®Google Scholar
• Baselt RC. Disposition of Toxic Drugs and Chemicals in Man, 7th Edn. Foster City: Biomedical Publications, 2004:678-82
   Google Scholar
• Yaksh TL, Wallace MS. Opioids, analgesia, and pain management. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman & Gillman’s The Pharmacologic Basis of Therapeutics, 12th Edn. New York: McGraw Hill, 2011:506-7
   Google Scholar
• Raffa RB, Friderichs E, Reimann W, et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an ‘atypical’ opioid analgesic. J Pharmacol Exper Ther 1992;260:275-85
   PubMed Web of Science ®Google Scholar
• Raffa RB, Friderichs E, Reimann W, et al. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther 1993;267:331-40
   PubMed Web of Science ®Google Scholar
• Raffa RB, Friderichs E. The basic science aspect of tramadol hydrochloride. Pain Rev 1996;3:249-71
   Google Scholar
• Barkin RL. Extended-release tramadol (Ultram ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain. Am J Therap 2008;15:157-66
   PubMed Web of Science ®Google Scholar
• Pergolizzi JV, Taylor R, Raffa RB. Extended-release formulations of tramadol in the treatment of chronic pain. Expert Opin Pharmacother 2011;12:1757-68
   PubMed Web of Science ®Google Scholar
• Rosenberg MT. The role of tramadol ER in the treatment of chronic pain. Clin Practice 2009;63:1531-43
   Google Scholar
• Bartholomaeus JH, Arkenau-Maric E, et al. Opioid extended-release tablets with improved tamper-resistant properties. Expert Opin Drug Deliv 2012;9:879-91
   PubMed Web of Science ®Google Scholar
• Pergolizzi J, Alon E, Baron R, et al. Tapentadol in the management of chronic low back pain: a novel approach to a complex condition? J Pain Res 2011;4:203-10
   PubMedGoogle Scholar
• Vadivelu N, Timchenko A, Huang Y, et al. Tapentadol extended-release for treatment of chronic pain: a review. J Pain Res 2011;4:211-18
   PubMedGoogle Scholar
• Lacy CF, Armstrong LL, Goldman MP, et al., eds. Drug Information Handbook with International Trade Names Index, 20th Edn. Hudson: Lexi-Comp Inc., 2011:243-6
   Google Scholar
• Boas RA, Villiger JW. Clinical actions of fentanyl and buprenorphine. The significance of receptor binding. Br J Anaesth 1985;57:192-6
   PubMed Web of Science ®Google Scholar
• Pergolizzi J, Aloisi AM, Dahan A, et al. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract 2010;10:428-50
   PubMed Web of Science ®Google Scholar
• Dahan A, Yassen A, Romberg R, et al. Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth 2006;96:627-32
   PubMed Web of Science ®Google Scholar
• Llorca PM. Discussion of prevalence and management of discomfort when swallowing pills: orodispersible tablets expand treatment options in patients with depression. Ther Deliv 2011;2:611-22
   PubMedGoogle Scholar
• Berdot S, Sabatier B, Gillaizeau F, et al. valuation of drug administration errors in a teaching hospital. BMC Health Serv Res 2012;12:60
   PubMed Web of Science ®Google Scholar
• Ghaleb MA, Barber N, Franklin BD, et al. The incidence and nature of prescribing and medication administration errors in paediatric inpatients. Arch Dis Child 2010;95:113-18
   PubMed Web of Science ®Google Scholar
• Lesar TS. Prescribing errors involving medication dosage forms. J Gen Intern Med 2002;17:579-87
   PubMed Web of Science ®Google Scholar
• McPhillips HA, Stille CJ, Smith D, et al. Potential medication dosing errors in outpatient pediatrics. J Pediatr 2005;147:761-7
   PubMed Web of Science ®Google Scholar
• Kaushal R, Goldmann DA, Keohane CA, et al. Medication errors in paediatric outpatients. Qual Saf Health Care 2010;19:e30
   PubMedGoogle Scholar
• Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001;285:2114-20
   PubMed Web of Science ®Google Scholar
• Lee BH, Lehmann CU, Jackson EV, et al. Assessing controlled substance prescribing errors in a pediatric teaching hospital: an analysis of the safety of analgesic prescription practice in the transition from the hospital to home. J Pain 2009;10:160-6
   PubMed Web of Science ®Google Scholar
• Wong IC, Ghaleb MA, Franklin BD, et al. Incidence and nature of dosing errors in paediatric medications: a systematic review. Drug Saf 2004;27:661-70
   PubMed Web of Science ®Google Scholar
• Cornish P. Avoid the crush: hazards of medication administration in patients with dysphagia or a feeding tube. CMAJ 2005;172:871-2
   PubMed Web of Science ®Google Scholar
• Nissen LM, Haywood A, Steadman KJ. Solid medication dosage form modification at the bedside and in the pharmacy of Queensland Hospitals. J Pharm Pract Res 2009;39:129-34
   Google Scholar
• Stanos SP, Bruckenthal P, Barkin RL. Strategies to reduce the tampering and subsequent abuse of long-acting opioids: potential risks and benefits of formulations with physical or pharmacologic deterrents to tampering. Mayo Clin Proc 2012;87:683-94
   PubMed Web of Science ®Google Scholar
• Kelly J, Wright D, Wood J. Medication errors in patients with dysphagia. Nurs Times 2012;108:12-14
   Google Scholar
• Kelly J, D’Cruz G, Wright D. Patients with dysphagia: experiences of taking medication. J Adv Nurs 2010;66:82-91
   PubMed Web of Science ®Google Scholar
• Kelly J, D’Cruz G, Wright D. A qualitative study of the problems surrounding medicine administration to patients with dysphagia. Dysphagia 2009;24:49-56
   PubMed Web of Science ®Google Scholar
• Smith HS, Lesar TS. Analgesic prescribing errors and associated medication characteristics. J Pain 2011;12:29-40
   PubMed Web of Science ®Google Scholar
• Lesar TS, Lomaestro BM, Pohl H. Medication-prescribing errors in a teaching hospital. A 9-year experience. Arch Intern Med 1997;157:1569-76
   PubMed Web of Science ®Google Scholar
• Avinza (Morphine Sulfate Extended-release Capsules) [Package Insert]. Bristol, TN: King Pharmaceuticals Inc., 2014
   Google Scholar
• Kadian (Morphine Sulfate Extended-release Capsules) [Package Insert]. Morristown, NJ: Actavis Kadian LLC, 2014
   Google Scholar
• Reder RF. Opioid formulations: tailoring to the needs in chronic pain. Eur J Pain 2001;5(Suppl A):109-11
   PubMed Web of Science ®Google Scholar
• MSContin (Morphine Sulfate Controlled-release) [Package Insert]. Stamford, CT: Purdue Pharma LP, 2014
   Google Scholar
• Oramorph SR (Morphine Sulfate Sustained-release) [Package Insert]. Newport, KY. Xanodyne Pharmaceuticals Inc., 2006
   Google Scholar
• Webster LR, Fine PG. Approaches to improve pain relief while minimizing opioid abuse liability. J Pain 2010;11:602-11
   PubMed Web of Science ®Google Scholar
• Embeda (Morphine Sulfate and Naltrexone HCl Extended-release). New York, NY: Pfizer Inc., 2014
   Google Scholar
• OxyContin (Oxycodone HCl Controlled-release) [Package Insert]. Stamford, CT: Purdue Pharma LP, 2014
   Google Scholar
• Purdue Pharma. FDA accepts for review Purdue Pharma’s new drug application for Targiniq™ ER (oxycodone HCl/naloxone HCl controlled-release) tablets CII. Press release. 26 November 2013. Available at: http://www.purduepharma.com/news-media/2013/11/fda-accepts-for-review-purdue-pharmas-new-drug-application-for-targiniq-er-oxycodone-hclnaloxone-hcl-controlled-release-tablets-cii/ [Last accessed 22 August 2014]
   Google Scholar
• Targiniq ER (Oxycodone Hydrochloride and Naloxone Hydrochloride Extended-release Tablets) [Package Insert]. Stamford, CT: Purdue Pharma LP, 2014
   Google Scholar
• Opana ER (Oxymorphone HCl Tablet Extended-release) [Package Insert]. Malvern, PA: Endo Pharmaceuticals Inc., 2014
   Google Scholar
• Lussier D, Richarz U, Finco G. Use of hydromorphone, with particular reference to the OROS formulation, in the elderly. Drugs Aging 2010;27:327-35
   PubMed Web of Science ®Google Scholar
• Exalgo (Hydromorphone HCl Extended-release Tablets) [Package Insert]. Hazelwood, MO: Mallinckrodt Brand Pharmaceuticals Inc., 2014
   Google Scholar
• Duragesic (Fentanyl Transdermal System) [Package Insert]. Titusville, NJ: Janssen Pharmaceuticals Inc., 2014
   Google Scholar
• Butrans (Burprenorphine Patch Extended-release) [Package Insert]. Stamford, CT: Purdue Pharma LP, 2014
   Google Scholar
• Zohydro ER (Hydrocodone Bitartrate Extended-release Capsules) [Package Insert]. San Diego, CA: Zogenix Inc., 2014
   Google Scholar
• Nucynta (Tapentadol Extended-release Tablets) [Package Insert]. Titusville, NJ: Janssen Pharmaceuticals Inc., 2014
   Google Scholar
• Ultram (Tramadol HCl Extended-release Tablets) [Package Insert]. Titusville, NJ: Janssen Pharmaceuticals Inc., 2014
   Google Scholar
• Kokki H, Rasanen I, Reinikainen M, et al. Pharmacokinetics of oxycodone after intravenous, buccal, intramuscular and gastric administration in children. Clin Pharmacokin 2004;43:613-22
   PubMed Web of Science ®Google Scholar
• Kuhlman JJ Jr, Lalani S, Magluilo J Jr, et al. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine. J Analytic Toxicol 1996;20:369-78
   PubMed Web of Science ®Google Scholar
• Webster LR. Fentanyl buccal tablets. Exp Opin Invest Drugs 2006;15:1469-73
   PubMed Web of Science ®Google Scholar
• Nalamachu S, Hassman D, Wallace MS, et al. Long-term effectiveness and tolerability of sublingual fentanyl orally disintegrating tablet for the treatment of breakthrough cancer pain. Curr Med Res Opin 2011;27:519-30
   PubMed Web of Science ®Google Scholar
• Hagen NA, Moulin DE, Brasher PM, et al. A formal feasibility study of sublingual methadone for breakthrough cancer pain. Palliat Med 2010;24:696-706
   PubMed Web of Science ®Google Scholar
• Grassin-Delyle S, Buenestado A, Naline E, et al. Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. Pharmacol Ther 2012;134:366-79
   PubMed Web of Science ®Google Scholar
• Dale O, Hjortkjaer R, Kharasch ED. Nasal administration of opioids for pain management in adults. Acta Anaesth Scand 2002;46:759-70
   PubMed Web of Science ®Google Scholar
• Mostafa MG, Morsy KM. Premedication with intranasal dexmedetomidine, midazolam and ketamine for children undergoing bone marrow biopsy and aspirate. Egyptian J Anaesth 2013;29:131-5
   Google Scholar
• Farr SJ, Otulana BA. Pulmonary delivery of opioids as pain therapeutic. Adv Drug Deliv Rev 2006;58:1076-88
   PubMed Web of Science ®Google Scholar
• Paech MJ, Bloor M, Schug SA. New formulations of fentanyl for acute pain management. Drugs of Today 2012;48:119-32
   PubMed Web of Science ®Google Scholar
• van Hoogdalem E, de Boer AG, Breimer DD. Pharmacokinetics of rectal drug administration Part I. General considerations and clinical applications of centrally acting drugs. Clin Pharmacokinet 1991;21:11-26
   PubMed Web of Science ®Google Scholar
• Li CG, Huang XE, Li Y, Lu YY. Clinical observations on safety and efficacy of OxyContin administered by rectal route in treating cancer related pain. Asian Pac J Cancer Preven 2011;12:2477-8
   PubMed Web of Science ®Google Scholar
• Riad W, Moussa A. Pre-operative analgesia with rectal diclofenac and/or paracetamol in children undergoing inguinal hernia repair. Anaesthesia 2007;62:1241-5
   PubMed Web of Science ®Google Scholar
• Flores MP, Castro AP, Nascimento JdS. Topical analgesics. Rev Bras Anestesiol 2012;62:244-52
   PubMed Web of Science ®Google Scholar
• Latta KS. Extemporaneous compounding of pain and symptom control medications. J Pain Palliat Care Pharmacother 2002;16:51-60
   PubMedGoogle Scholar
• Deer TR, Prager J, Levy R, et al. Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation 2012;15:436-64, discussion 464-6
   PubMed Web of Science ®Google Scholar
• Winn SR, Emerich DF. Managing chronic pain with encapsulated cell implants releasing catecholamines and endogenous opioids. Frontiers Biosci 2005;10:367-78
   PubMed Web of Science ®Google Scholar
• Ommaya AK. Subcutaneous reservoir and pump for sterile access to ventricular cerebrospinal fluid. Lancet 1963;282:983-4
   Google Scholar
• Ommaya AK, Rubin RC, Henderson ES, et al. A new approach to the treatment of inoperable brain tumors. Med Ann Dist Columbia 1965;34:455-8
   PubMedGoogle Scholar
• Kopecky EA, Fleming A, Noonan P, et al. Impact of physical manipulation on in vitro and in vivo release profiles of oxycodone DETERx®: an extended-release, abuse-deterrent formulation. J Opioid Manag 2014;10;233-46
   Google Scholar
• Kopecky EA, Fleming A, Findlen K, et al. Oxycodone DETERx; an extended-release, abuse-deterrent formulation for management of patients with chronic pain and chronic pain with dysphagia. J Pain 2014;15:S90
   PubMed Web of Science ®Google Scholar